Shire Pharmaceuticals Initiates Voluntary Nationwide Recall of One Batch, Packaged into Three Lots, of VPRIV® (velaglucerase alfa for injection) http://www.fda.gov/Safety/Recalls/ucm389304.htm 03/14/14
VPRIV (Velaglucerase Alfa for injection) a medicine used for long-term enzyme replacement therapy (ERT) in pediatric and adult patients with type 1 Gaucher disease., by Shire Pharmaceuticals, Recalled due to Visible Particulate Matter #RecalledProducts #GaucherDisease
Shire Pharma says No - won’t save dying 6 year-old February 2, 2014. Mundelein, IL. Six year-old Jack Fowler is dying and Massachusetts-based Shire Pharmaceutical won’t help him. According to Shire CEO Flemming Ornskov, his corporation isn’t in the business of helping people. And that’s a shame. Because an army of doctors, donors, facilities and volunteers have come together to save Jack’s life. But they can’t do it without Shire Pharma.